+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tolterodine"

From
From
From
From
From
Overactive Bladder - Pipeline Insight, 2021 - Product Thumbnail Image

Overactive Bladder - Pipeline Insight, 2021

  • Drug Pipelines
  • July 2021
  • 60 Pages
  • Global
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Tolterodine is a medication used to treat symptoms of overactive bladder, such as frequent urination, urgency, and incontinence. It is a muscarinic receptor antagonist, which works by blocking the action of a chemical messenger in the muscles of the bladder. Tolterodine is part of a class of drugs known as antimuscarinics, which are commonly used to treat urological disorders. Tolterodine is available in both immediate-release and extended-release formulations, and is typically taken twice daily. Common side effects include dry mouth, constipation, and blurred vision. It is important to note that tolterodine should not be used in patients with certain medical conditions, such as glaucoma, urinary retention, or uncontrolled narrow-angle glaucoma. The tolterodine market is a subset of the larger urological disorders drugs market. It is a competitive market, with several companies offering tolterodine products. Some of the companies in the market include Allergan, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more